about
Multifunctional hybrid silica nanoparticles for controlled doxorubicin loading and release with thermal and pH dually response.Protein-mediated dethreading of a biotin-functionalised pseudorotaxane.Second generation specific-enzyme-activated rotaxane propeptides.Gated supramolecular chemistry in hybrid mesoporous silica nanoarchitectures: controlled delivery and molecular transport in response to chemical, physical and biological stimuli.Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery.Peptide amphiphile nanoparticles enhance the immune response against a CpG-adjuvanted influenza antigen.Poly(propylene imine) dendrimer caps on mesoporous silica nanoparticles for redox-responsive release: smaller is better.Membrane Fusion Mediated Intracellular Delivery of Lipid Bilayer Coated Mesoporous Silica Nanoparticles.An aptamer-gated silica mesoporous material for thrombin detection.γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release.Ceramics for Drug DeliveryMesoporous Silica Nanoparticles for Drug Delivery and Controlled Release ApplicationsCoiled-coil peptide motifs as thermoresponsive valves for mesoporous silica nanoparticlesCharge-reversal plug gate nanovalves on peptide-functionalized mesoporous silica nanoparticles for targeted drug deliverySilica-based multifunctional nanodelivery systems toward regenerative medicineSelective, Highly Sensitive, and Rapid Detection of Genomic DNA by Using Gated Materials:MycoplasmaDetectionFrom protected trialkoxysilyl-peptide building blocks to bioorganic–silica hybrid materials
P2860
Q30445141-6C1B2D0E-A3C7-4DC9-8752-B3F404A48ADDQ30702445-622446F2-F7A9-49C6-A6EC-2A5001162A21Q34121390-7230869B-B175-48D8-BCEB-5BCD6A3510DFQ38353035-9A9CAB9A-CF37-4C6B-8D1C-648319260159Q39237999-D90119FD-4C97-4C4B-8A5E-DDB70284F63EQ42273780-837CCD25-B45B-4B5E-8218-F046942E9590Q45249776-A7F682F1-EE0B-48E0-A021-E4226A492FC0Q47748906-7D3F14E0-536A-4833-AFE4-31DCD43DEAC7Q51006308-2BF4627F-B25B-4B01-B70F-E06D0208E817Q52976181-8BC81866-C373-4807-B126-6BB464504B4CQ57341098-2969D10B-1DF8-427B-9C80-52D967B66103Q57341237-DF5B2D97-642D-4F1F-8C66-4EB70BBF70E6Q57364652-1B25DA66-D697-4F2B-AEC1-B690112A00BDQ57365143-015268C2-A5F1-4F88-94F6-4A6BDDA8212CQ57367659-E6782AEE-8C34-4611-985A-6F4EFD0269A8Q57401142-DB8C57D2-37C5-4291-AB7C-0F5E0B1E25ACQ58100488-DE2585B1-BB9A-4D4F-B7F8-7CF4F439A9DC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Peptide modified mesoporous silica nanocontainers.
@en
Peptide modified mesoporous silica nanocontainers.
@nl
type
label
Peptide modified mesoporous silica nanocontainers.
@en
Peptide modified mesoporous silica nanocontainers.
@nl
prefLabel
Peptide modified mesoporous silica nanocontainers.
@en
Peptide modified mesoporous silica nanocontainers.
@nl
P2093
P2860
P356
P1476
Peptide modified mesoporous silica nanocontainers
@en
P2093
Fabiola Porta
Gerda E M Lamers
Jeffrey I Zink
P2860
P304
P356
10.1039/C0CP02959A
P407
P577
2011-06-01T00:00:00Z